The influence of changes in catecholamine metabolism on tetrahydrobiopterin biosynthesis was investigated in cultured rat pheochromocytoma PC12 cells. The increase in the cellular dopamine content after treatment with the MAO-COMT inhibitor or dopamine produced decreases in the GTP-cy· clohydrolase I (GTPCH-I) activity and total biopterin content. On the contrary, the catecholamine increase after treatment with nerve growth factor produced increases in the GTPCH -I activity and total biopterin content. On the other hand, the decrease in the dopamine content after tyrosine hydroxylase (TH) inhibitor treatment produced decreases in the GTPCH-I activity and total biopterin content, but the catecholamine decrease (the DOPA content increased about 3.4-fold) after aromatic L-amino acid decarboxylase inhibitor treatment produced a decrease in the GTPCH-I activity. These results suggest that an increase in dopamine content that is not directly related to the action of TH plays a role in down-regulation of tetrahydrobiopterin biosynthesis and that when the changes in catecholamine metabolism are stro~gly associated with the action of TH, tetrahydrobiopterin biosynthesis is regulated depending on the necessity for TH.
Introduction
GTP cyclohydrolase I (EC 3.4.5.16; GTPCH-I) is the enzyme that catalyzes the formation of Derythro-dihydroneopterin triphosphate from GTP ( 1 ) . This is the first step in tetrahydrobiopterin biosynthesis. This biopterin is a cofactor of aromatic amino acid hydroxylase, which cnalyzes the biosynthesis of catecholamines and 5-hydroxy-tryptamine (2, 3) , and presumably is an essential factor for the production of nitric oxide (NO) from arginine (4) . Nitric oxide has been widely studied regarding its role in the immune system and apoptosis as well as in neurochemistry. Since GTPCH-I is the rate-limiting enzyme in many mammals, although not in man (5) , and since the concentration of tetrahydrobiopterin affects catecholamine synthesis (6) (7) (8) , we sought to determine whether a decrease in catecholamine would cause an increase in biopterin, and conversely whether an increase in catecholamine would cause a decrease in biopterin.
A clonal line from a rat pheochromocytoma, PC12 cells (9) , has either catecholamine-or tetra-hydrobiopterin-metabolizing enzymes . In this study, enzyme inhibitors such as a-methyl p -tyrosine (a-MPT) , a-hydrazine-m-cresol dihydrochloride (NSD-I0lS), tranylcypromine hydrochloride, and 3,S-dinitrocatechol, which are inhibitors for tyrosine hydroxylase (ECl.14.16 .2; TH), aromatic L-amino acid decarboxylase (EC 4.1 .1 .2S; AADC), monoamine oxidase (EC 1.4.3.4; MAO), and catechol o-methyltransferase ( EC 2 .1.1.6; COMT), respectively, were added to a culture media of PC12 cells to decrease or increase the catecholamine contents . GTPCH-I activity and total biopterin contents as a quantitative index of tetrahydrobiopterin, which is a major biopterin in PC 12 cells (10) , and catecholamine contents in the PC12 cells were then measured . Nerve growth factor (NGF), which have been well established to produce activation of tyrosine hydroxylase in PC12 cells , was also used to cause an increase in catecholamine contents of the cells .
Materials and Methods
Clonal pe12 cells were obtained from the Japanese Cancer Resources Bank ( RCB009, Tokyo, Japan) . Dulbecco's modified Eagle's medium (Gibco BRL lS070-63), a mixture of S,OOO J.!g/ ml of streptomycin and S,OOO units/ ml of penicillin ( Gibco BRL 12100-046), and fetal calf serum (Gibco BRL 10099-141) were purchased from Life Tech Oriental (Tokyo, Japan). a-MPT, NSD-I01S, tranylcypromine hydrochloride, and 3, S-dinitro-catechol were obtained from Research Biochemicals International (Natic, MA., USA) . Alkaline phosphatase (Type VII-S : from bovine intestinal mucosa) and all standards for biopterin, neopterin, 3,4-dihydroxyphenylalanine (DOPA), and dopamine (DA) were from Sigma (St. Louis, MO , USA). NGF was purchased from Upstate Biotechnology (Lake Placid, NY, USA), and guanosine Sf-triphosphate (GTP)disodium salt, from Wako Pure Chemical (Osaka, Japan) . Centrifuge tubes with a 0.4S-J.!m pore size membrane filter (Millipore Ultrafree-MC, UFC30HVO) and a 10k-molecular weight exclusion size membrane filter were purchased from Japan Millipore, Tokyo, Japan. Deverosil-ODS, K-S, 4.6 x 2S0 mm) column was purchased from Nomura Chemical (Aichi, Japan). All other reagents were analytical grade.
Cell Culture
PC12 cells were grown in Dulbecco's modified Eagle's medium supplemented with 7.S% fetal calf Pterictines/ Vol. 9 / No. 1 serum, 100 I-lg/ ml of streptomycin and 100 units/ ml of penicillin . The cells were maintained in plastic flasks at 3TC in an atmosphere containing S% CO 2 , The PC12 cells were splited at a 1:6 or l:S ratio each week, and the medium was changed once between splits.
Experiments with PC12 Cells
The cells were treated in a culture flask with NGF (SO ng/ml), NSD-I01S (SOO J.!M), a-MPT ( ISO I-lM ) or a mixture of tranylcypromine hydrochloride and 3 ,S-dinitrocatechol (10 J.!M each, indicated as MAO -COMT inhibitor) for 24 hr. At the end of the experiment, the medium was removed by aspiration, the cells were detached by a scraper into cold phosphate-buffered saline (PBS) containing 0.2 mM phenylmethylsultonyl fluoride (PMSF) and centrifuged at 1,SOO x g for 10 min at 4°C. The collected cells were washed with the same buffer twice, centrifuged at 12,000 X g for 10 min at 4°C to collect the cells, and stored in a -SOuC deep freezer until analyzed .
Three flasks were prepared for each experiment and duplicate determinations were carried out for each flask. The mean value, at least, was calculated from six determinations of two experiments for each agent.
Assay for GTP cyclohydrolase I
The washed cells were sonicated four times in about five volumes of homogenizing buffer A (SO mM potassium phosphate buffer, pH 7.0 containing 1 mM EDTA and 0.2 mM PMSF) at 20 VV for 30 sec at 4°C with a Bioptor sonicator (COSMO BIO, Tokyo, Japan) four times . The supernatant solution obtained after centrifugation at 12,000 X g for 30 min was used for the enzyme assays.
The enzyme activity was assayed according to the methods described by Sawada et al . ( 11) and Hatakeyama et al. (12) . The reaction mixture (100 J.!l) contained 10 J.!l of 10 mM GTP, 10 J.!l of 2S mM EDTA, 10 J.!l of 1 M Tris, pH 7.S, containing O.S M KCI, 20 J.!l of SO% glycerol, and SO J.!I of enzyme preparation, and incubated at 37°C for 60 min in the dark. After the incubation, the mixture was oxidized by the addition of 10 J.!l of a solution containing 1% iodine and 2% KI in 1 N H CI in the dark for 60 min, and the oxidative reaction was terminated by the addition of 10 J.!l of 2% ascorbic acid. Neopterin triphosphate formed was de phosphorylated by the addition of 13 J.!l of 2 M NaOH followed by 9 units ( 15 /-ll ) of alkaline phosphatase and subsequent incubation for 60 m.in at 37"C in the dark . The reaction was terminated b y the addition of 13 /-ll of 2 M acetic acid solution . After centrifugation, the supernatant solution was injected into a HPLC column ( Deverosil-ODS, K-5 ). HPLC was pertcmned with a JASCO Trirotor (Nihon Bunko, Tokyo, Japan) equipped with a spectrofluorometer (FP-210 Spectrofluorometer, Nihon Bunko, Tokyo, Japan ). The fluorescence was measured at 450 nm with excitation at 350 nm. The mobile phase buffer for the HPLC was 10 mM sodium phosphate buficr, pH 7.0, containing 1 mM EDTA, and the flow rate was set at 1 .0 ml/ min.
Measurement of total biopterins
Total biopterins in the cell preparation were determined by the method for GTP cyclohydrolase I with a little modification; i.e ., the supernatant of the sonicated preparation that resulted from centrifugation at 12,000 x g for 20 min was directly analyzed b y HPLC without incubation for determination of GTP cyclohydrolase I activity at the oxidation step.
Measurement of DOPA and dopamine
The washed cells were . sonicated in about 10 volumes of 0.1 M perchloric acid and treated in the same manner as described for the GTPCH-I assay.
The supernatant obtained from the centrifugation at 12,000 x g for 20 min was then filtered through a centrifuge tube with a 0.45/-lm pore size membrane filter during centrifugation at 12, 000 x g . The filtrate was further filtered through another centrifuge tube with a 10 k-molecular weight exclusion size membrane filter.
Protein determination
Protein concentration was determined by the method of Lowry et al. ( 13 ) with bovine serum albumin as a standard.
Statistical analysis
All analyses were conducted in triplicate, and values summary statistics were expressed as mean ± standard deviation (SD). Student's t test was used to compare mean differences. Difference were considered to be significant at p < 0.05.
Result

Influence of treatment with the various agents on DA content
The changes in the DA content following treatment with the various agents are shown in Table 1 .
The DA content per unit weight of protein after treatment with the AADC and TH inhibitors decreased to become about 27% and 45%, respectively, and that after treatment with NGF and the MAO-COMT inhibitors increased to a value about l.4-fold (p<0 .05 ) and 2.9-fold (p<0.05), respectively, compared with that of the control.
The DOPA content after treatment with AADC and MAO-COMT inhibitors was also determined and was found to be about 3.4-fold (p < 0.05) and 1.3-fold (no significant difference), respectively , higher than that of the control. The content after treatment with the other agents was not measured.
The NE content in the PC12 cells was lower than the sensitivity limit of this method and was probably less than 10% of the DA content.
Neither the inhibitors of AADC and TH nor MAO-COMT, NGF (14, 15) , and DA significantly affected the assay for GTPCH -I activity.
Influence of treatment with the various agents on GTPCH-I activity and total biopterin content
The changes in the GTPCH-I activity and total biopterin content after treatment with the various agents are also shown in Table 1 .
The GTPCH -I activity was decreased to a value ranging about 50% to 60% of the control by the agents, except for NGF, in which case the activity was about 1.6-fold (p < 0.05) over the control value.
The total biopterin contents hardly changed after treatment with the AADC inhibitor, was slightly increased, about 1.2-fold, after treatment with NGF (p < 0.05), and decreased after treatment with TH inhibitor and MAO-COMT inhibitor (p < 0 .05) .
Discussion
The increase in DA content after treatment with the MAO-COMT inhibitor, which are not directly related to the action of tyrosine hydroxylase, produced decreases in both GTPCH-I activity and content of total biopterins, which are oxidized products of tetrahydrobiopterin, a cofactor of TH. These results are considered to reflect down-regulation of tetrahydrobiopterin .
The DA content also increased due to the activation ofTH after treatment with NGF (16, 17) . However, the NGF treatment produced an elevation of the GTPCH -I activity and a little increase in the total biopterin content. These phenomena are thought to be due to the induction of GTPCH-I, an enzyme for tetrahydrobiopterin biosynthesis required for TH (15, 18) .
The elevation of tetrahydrobiopterin biosynthesis in PC12 cells by NGF most likely occurs as follows: NGF elevates the cAMP concentration (16, 17) and cAMP promotes the phosphorylation of both TH and GTPCH-I, which thereby activates their enzymic activities (15) .
On the other hand, the decrease in the DA content after treatment with a-MPT, the TH inhibitor, caused decreases in the GTPCH -I activity and total biopterin content. This may due to the direct inhibition of TH activity so that the enzyme does not require its cofactor.
A similar change was also evident after treatment of the cells with the AADC inhibitor; both DA content and GTPCH-I activity decreased. The AADC inhibitor NSD-I015 is thought not Pteridines/ Vol. 9 / No. 1 to inhibit TH activity, the DOPA content increased to become about 3.4-fold compared with that of the control after treatment with NSD-1015. There is no information about the regulation of TH activity by DOPA, but the lllcrease in the DOPA content might decrease the requirement or need for the action of TH.
In spite of the fact that the GTPCH -I activity was decreased by the AADC inhibitor, the total biopterin content was hardly changed. The reason for this phenomenon is not known. A side pathway for tetrahydrobiopterin production involving no GTPCH -I action has been proposed (19) .
The DA decrease was also produced by the TH inhibitor treatment, but the total biopterin content decreased after this treatment . Although the DOPA content after the AADC inhibitor treatment increased, the content of this amino acid after the TH inhibitor treatment should naturally decrease on the contrary . The differences in the DOPA content between these two conditions might influences tetrahydrobiopterin biosynthesis in different manners.
Some of the results of this study can not explain previous results that DA elevates cAMP concentration in PC12 cells (20) and that cAMP should stimulates phosphorylation and activate GTPCH-I (15) . Further study of the regulatory mechanisms governing tetrahydrobiopterin metabolism is obviously required.
